Lupin receives USFDA approval for Iloperidone Tablets

8 May 2022 , 01:31 AM

Lupin today announced that it has received approval from the United States Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA Iloperidone Tablets 1 mg 2 mg 4 mg 6 mg 8 mg 10 mg and 12 mg to market a generic equivalent of Fanapt Tablets 1 mg 2 mg 4 mg 6 mg 8 mg 10 mg and 12 mg of Vanda Pharmaceuticals Inc The product will be manufactured at Lupins facility in Goa India Iloperidone Tablets RLD Fanapt had estimated annual sales of USO 162 million in the US IQVIA MAT March 2022